Novo Nordisk inventory hits all-time excessive as Wegovy boosts 2023 outcomes (NYSE:NVO)


Novo Nordisk office in Fremont, California, USA

JHVEPhoto/iStock Editorial by way of Getty Pictures

Novo Nordisk (NVO) shares on Wednesday reached an all-time excessive because it reported a robust monetary efficiency for 2023 on the again of its diabetes and weight problems care portfolio.

Shares have gained +57.11% during the last 12 months and touched

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles